Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J A Millar

Showing results (1-10 of 101) with videos related to

Pageof 11
Sort By:
Lancet (London, England)|June 15, 1996
Seasonal incidence of strokeJ A Millar
Journal of Human Hypertension|March 3, 1998
Shortcomings in the trough to peak ratio as a guide to the dose interval for antihypertensive drugsJ A Millar
Monash Bioethics Review|April 7, 2005
Is the Australian HREC system unsustainable?J A Millar
Lancet (London, England)|November 12, 1988
Changing criteria for mild hypertension: effect on number of patients treatedJ A Millar
Internal Medicine Journal|September 23, 2009
Selection of medical patients for prophylaxis of venous thromboembolism based on analysis of the benefit-hazard ratioJ A Millar
The New Zealand Medical Journal|September 13, 1989
Treatment of hypertensionJ A Millar
Clinical and Experimental Pharmacology & Physiology|March 1, 1995
Economic comparison of drug and lifestyle treatment of cardiovascular risk factors in high-risk patientsJ A Millar
Australian and New Zealand Journal of Medicine|February 1, 1996
Limitations in the 'area under the curve' method for predicting daily doses of gentamicinJ A Millar
The New Zealand Medical Journal|February 26, 1992
Unit tablet size of antihypertensive drugsJ A Millar
Clinica Chimica Acta; International Journal of Clinical Chemistry|May 2, 1977
Antibody/label binding curve in radioimmunoassayJ A Millar
Pageof 11

Showing results (1-10 of 101) with videos related to

Sort By:
Pageof 11
Lancet (London, England)|June 15, 1996
Seasonal incidence of strokeJ A Millar
Journal of Human Hypertension|March 3, 1998
Shortcomings in the trough to peak ratio as a guide to the dose interval for antihypertensive drugsJ A Millar
Monash Bioethics Review|April 7, 2005
Is the Australian HREC system unsustainable?J A Millar
Lancet (London, England)|November 12, 1988
Changing criteria for mild hypertension: effect on number of patients treatedJ A Millar
Internal Medicine Journal|September 23, 2009
Selection of medical patients for prophylaxis of venous thromboembolism based on analysis of the benefit-hazard ratioJ A Millar
The New Zealand Medical Journal|September 13, 1989
Treatment of hypertensionJ A Millar
Clinical and Experimental Pharmacology & Physiology|March 1, 1995
Economic comparison of drug and lifestyle treatment of cardiovascular risk factors in high-risk patientsJ A Millar
Australian and New Zealand Journal of Medicine|February 1, 1996
Limitations in the 'area under the curve' method for predicting daily doses of gentamicinJ A Millar
The New Zealand Medical Journal|February 26, 1992
Unit tablet size of antihypertensive drugsJ A Millar
Clinica Chimica Acta; International Journal of Clinical Chemistry|May 2, 1977
Antibody/label binding curve in radioimmunoassayJ A Millar
Pageof 11